Synthetic modified messenger RNA for therapeutic applications

信使核糖核酸 生物 计算生物学 重编程 遗传增强 合成生物学 免疫原性 基因 免疫系统 遗传学
作者
Minsong Gao,Qingyi Zhang,Xin‐Hua Feng,Jianzhao Liu
出处
期刊:Acta Biomaterialia [Elsevier]
卷期号:131: 1-15 被引量:32
标识
DOI:10.1016/j.actbio.2021.06.020
摘要

Synthetic modified messenger RNA (mRNA) has manifested great potentials for therapeutic applications such as vaccines and gene therapies, with the recent mRNA vaccines for global pandemic COVID-19 (corona virus disease 2019) attracting the tremendous attention. The chemical modifications and delivery vehicles of synthetic mRNAs are the two key factors for their in vivo therapeutic applications. Chemical modifications like nucleoside methylation endow the synthetic mRNAs with high stability and reduced stimulation of innate immunity. The development of scalable production of synthetic mRNA and efficient mRNA formulation and delivery strategies in recent years have remarkably advanced the field. It is worth noticing that we had limited knowledge on the roles of mRNA modifications in the past. However, the last decade has witnessed not only new discoveries of several naturally occurring mRNA modifications but also substantial advances in understanding their roles on regulating gene expression. It is highly necessary to reconsider the therapeutic system made by synthetic modified mRNAs and delivery vectors. In this review, we will mainly discuss the roles of various chemical modifications on synthetic mRNAs, briefly summarize the progresses of mRNA delivery strategies, and highlight some latest mRNA therapeutics applications including infectious disease vaccines, cancer immunotherapy, mRNA-based genetic reprogramming and protein replacement, mRNA-based gene editing. The development of synthetic mRNA drug holds great promise but lies behind small molecule and protein drugs largely due to the challenging issues regarding its stability, immunogenicity and potency. In the last 15 years, these issues have beensubstantially addressed by synthesizing chemically modified mRNA and developing powerful delivery systems; the mRNA therapeutics has entered an exciting new era begun with the approved mRNA vaccines for the COVID-19 infection disease. Here, we provide recent progresses in understanding the biological roles of various RNA chemical modifications, in developing mRNA delivery systems, and in advancing the emerging mRNA-based therapeutic applications, with the purpose to inspire the community to spawn new ideas for curing diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
热情面包完成签到 ,获得积分10
1秒前
ll完成签到,获得积分10
2秒前
zdx1022完成签到,获得积分10
2秒前
一只酸苹果完成签到,获得积分10
2秒前
jingganghao完成签到,获得积分10
2秒前
cctv18应助野性的岂愈采纳,获得10
2秒前
漂亮白云完成签到 ,获得积分10
3秒前
山野桃饼完成签到,获得积分10
3秒前
雍初南发布了新的文献求助10
4秒前
爱吃芒果果儿完成签到 ,获得积分10
4秒前
龚嫦君完成签到,获得积分20
4秒前
唐小其发布了新的文献求助10
4秒前
hl413完成签到,获得积分10
5秒前
文静灵阳完成签到 ,获得积分10
5秒前
Abner完成签到,获得积分20
5秒前
wxy发布了新的文献求助10
5秒前
orixero应助evilbatuu采纳,获得10
7秒前
权翼完成签到,获得积分10
8秒前
yyy完成签到,获得积分10
8秒前
科研通AI2S应助荣冥幽采纳,获得10
9秒前
学术狗发布了新的文献求助10
9秒前
ENIX完成签到,获得积分10
10秒前
gugugaga完成签到,获得积分10
11秒前
研友_Z60x5L完成签到 ,获得积分10
11秒前
楠易完成签到 ,获得积分10
12秒前
雨雨雨雨雨文完成签到 ,获得积分10
12秒前
flyfh完成签到 ,获得积分10
13秒前
Alice完成签到,获得积分10
13秒前
相爱就永远在一起完成签到,获得积分10
14秒前
...完成签到 ,获得积分10
14秒前
潇潇完成签到,获得积分10
15秒前
无辜的行云完成签到 ,获得积分0
15秒前
16秒前
呋喃发布了新的文献求助10
16秒前
毛毛球完成签到,获得积分10
16秒前
天天快乐应助唐小其采纳,获得10
17秒前
王小花完成签到,获得积分10
17秒前
柑橘完成签到,获得积分10
18秒前
高分求助中
좌파는 어떻게 좌파가 됐나:한국 급진노동운동의 형성과 궤적 2500
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Cognitive linguistics critical concepts in linguistics 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
氟盐冷却高温堆非能动余热排出性能及安全分析研究 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3052685
求助须知:如何正确求助?哪些是违规求助? 2709958
关于积分的说明 7418667
捐赠科研通 2354578
什么是DOI,文献DOI怎么找? 1246164
科研通“疑难数据库(出版商)”最低求助积分说明 605951
版权声明 595925